Royal Marsden update

Update Report: The Platinum Study While we are close to achieving 95 per cent cure rates for testicular cancer, it is more important than ever that we ensure survivors are able to enjoy a good quality of life beyond cancer. The highly effective anti-cancer drug, cisplatin, is routinely prescribed to testicular cancer patients. However, some …

Royal Marsden update Read More »

The Platinum Study – A message from Professor Robert Huddart

“We are so grateful to The Josh Carrick Foundation and all your amazing fundraisers and supporters for funding research at The Royal Marsden to help improve the quality of life for testicular cancer survivors. More people than ever are surviving testicular cancer, however many suffer from long-term side-effects like nerve damage and hearing loss. Your …

The Platinum Study – A message from Professor Robert Huddart Read More »